Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margret Merino

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Adolescent and Young Adult Oncology|March 19, 2020
Dissociation of Pubertal Development Abnormality and Gonadal Dysfunction in Childhood Cancer SurvivorsBo Yu, Rani Fritz, Mario Vega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Irreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall SurvivalMargret Merino, Yvette Kasamon, Marc Theoret, et al.
Pediatric Blood & Cancer|September 8, 2020
FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patientsMargret Merino, Nicholas Richardson, Gregory Reaman, et al.
Pediatric Blood & Cancer|May 13, 2022
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphomaMargret Merino, Yvette Kasamon, Hongshan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug AdministrationAndrew D J Pearson, Elly Barry, Yael P Mossé, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Adolescent and Young Adult Oncology|March 19, 2020
Dissociation of Pubertal Development Abnormality and Gonadal Dysfunction in Childhood Cancer SurvivorsBo Yu, Rani Fritz, Mario Vega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Irreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall SurvivalMargret Merino, Yvette Kasamon, Marc Theoret, et al.
Pediatric Blood & Cancer|September 8, 2020
FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patientsMargret Merino, Nicholas Richardson, Gregory Reaman, et al.
Pediatric Blood & Cancer|May 13, 2022
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphomaMargret Merino, Yvette Kasamon, Hongshan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug AdministrationAndrew D J Pearson, Elly Barry, Yael P Mossé, et al.
Pageof 1